fluoxetine has been researched along with Hyperprolactinaemia in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperprolactinemia was defined as a serum prolactin level greater than 16." | 2.72 | Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. ( Fava, M; Hilliker, SE; Klibanski, A; Miller, KK; Papakostas, GI; Petersen, T; Sklarsky, KG, 2006) |
| "Risperidone (N=45, 62%) was the most frequently prescribed antipsychotic drug, followed by olanzapine (24, 32%)." | 1.35 | Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. ( Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houston, JP | 1 |
| Fijal, B | 1 |
| Heinloth, AN | 1 |
| Adams, DH | 1 |
| Papakostas, GI | 1 |
| Miller, KK | 1 |
| Petersen, T | 1 |
| Sklarsky, KG | 1 |
| Hilliker, SE | 1 |
| Klibanski, A | 1 |
| Fava, M | 1 |
| Alacqua, M | 1 |
| Trifirò, G | 1 |
| Arcoraci, V | 1 |
| Germanò, E | 1 |
| Magazù, A | 1 |
| Calarese, T | 1 |
| Di Vita, G | 1 |
| Gagliano, C | 1 |
| Spina, E | 1 |
| Arya, DK | 1 |
| Taylor, WS | 1 |
| Snowden, H | 1 |
| Woolridge, M | 1 |
| Renfrew, M | 1 |
| Iancu, I | 1 |
| Ratzoni, G | 1 |
| Weitzman, A | 1 |
| Apter, A | 1 |
2 trials available for fluoxetine and Hyperprolactinaemia
| Article | Year |
|---|---|
Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Depression; Dose-Response | 2010 |
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.
Topics: Adult; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hyperprolactinemia; Male; Middle Aged | 2006 |
5 other studies available for fluoxetine and Hyperprolactinaemia
| Article | Year |
|---|---|
Drug-related hyperprolactinemia.
Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; H | 2003 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Ut | 2008 |
Lactation associated with fluoxetine treatment.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Dru | 1995 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Fluoxetine; Galactorrhea; HIV Infections; HIV Protease Inhibitors | 2001 |
More fluoxetine experience.
Topics: Adolescent; Bulimia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Gala | 1992 |